These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20142251)

  • 1. Association of global levels of histone modifications with recurrence-free survival in stage IIB and III esophageal squamous cell carcinomas.
    I H; Ko E; Kim Y; Cho EY; Han J; Park J; Kim K; Kim DH; Shim YM
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):566-73. PubMed ID: 20142251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global histone modifications predict prognosis of resected non small-cell lung cancer.
    Barlési F; Giaccone G; Gallegos-Ruiz MI; Loundou A; Span SW; Lefesvre P; Kruyt FA; Rodriguez JA
    J Clin Oncol; 2007 Oct; 25(28):4358-64. PubMed ID: 17906200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global histone modification pattern predicts poor prognosis in organic hyperinsulinism.
    Raffel A; Krausch M; Roushan K; Anlauf M; Henopp T; Hafner D; Lehwald N; Kröpil F; Schott M; Eisenberger CF; Knoefel WT; Stoecklein NH
    Horm Metab Res; 2011 Nov; 43(12):858-64. PubMed ID: 22105476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of global histone modifications in resected squamous cell carcinoma of the esophagus.
    Tzao C; Tung HJ; Jin JS; Sun GH; Hsu HS; Chen BH; Yu CP; Lee SC
    Mod Pathol; 2009 Feb; 22(2):252-60. PubMed ID: 18953329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global histone modification patterns predict risk of prostate cancer recurrence.
    Seligson DB; Horvath S; Shi T; Yu H; Tze S; Grunstein M; Kurdistani SK
    Nature; 2005 Jun; 435(7046):1262-6. PubMed ID: 15988529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma.
    Park YS; Jin MY; Kim YJ; Yook JH; Kim BS; Jang SJ
    Ann Surg Oncol; 2008 Jul; 15(7):1968-76. PubMed ID: 18470569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced acetylated histone H4 is associated with promoter methylation of the fragile histidine triad gene in resected esophageal squamous cell carcinoma.
    Tzao C; Sun GH; Tung HJ; Hsu HS; Hsu WH; Wang YC; Cheng YL; Lee SC
    Ann Thorac Surg; 2006 Aug; 82(2):396-401; discussion 401. PubMed ID: 16863736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal histone acetylation and methylation levels in esophageal squamous cell carcinomas.
    Chen C; Zhao M; Yin N; He B; Wang B; Yuan Y; Yu F; Hu J; Yin B; Lu Q
    Cancer Invest; 2011 Oct; 29(8):548-56. PubMed ID: 21843048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant methylation of Fragile Histidine Triad gene is associated with poor prognosis in early stage esophageal squamous cell carcinoma.
    Lee EJ; Lee BB; Kim JW; Shim YM; Hoseok I; Han J; Cho EY; Park J; Kim DH
    Eur J Cancer; 2006 May; 42(7):972-80. PubMed ID: 16564166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical study of modified Ivor-Lewis esophagectomy plus adjuvant radiotherapy for local control of stage IIA squamous cell carcinoma in the mid-thoracic esophagus.
    Chen G; Wang Z; Liu XY; Zhang MY; Liu FY
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):1-7. PubMed ID: 18926712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
    Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
    Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma.
    Yamamoto S; Tomita Y; Hoshida Y; Iizuka N; Kidogami S; Miyata H; Takiguchi S; Fujiwara Y; Yasuda T; Yano M; Nakamori S; Sakon M; Monden M; Aozasa K
    Clin Cancer Res; 2004 Aug; 10(16):5558-65. PubMed ID: 15328197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cytokeratin 7 predicts survival in stage I/IIA/IIB squamous cell carcinoma of the esophagus.
    Yamada A; Sasaki H; Aoyagi K; Sano M; Fujii S; Daiko H; Nishimura M; Yoshida T; Chiba T; Ochiai A
    Oncol Rep; 2008 Nov; 20(5):1021-7. PubMed ID: 18949396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cohypermethylation of p14 in combination with CADM1 or DCC as a recurrence-related prognostic indicator in stage I esophageal squamous cell carcinoma.
    Lee E; Lee BB; Ko E; Kim Y; Han J; Shim YM; Park J; Kim DH
    Cancer; 2013 May; 119(9):1752-60. PubMed ID: 23310950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global histone modification pattern associated with recurrence and disease-free survival in non-small cell lung cancer patients.
    Song JS; Kim YS; Kim DK; Park SI; Jang SJ
    Pathol Int; 2012 Mar; 62(3):182-90. PubMed ID: 22360506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy.
    Chao YK; Chan SC; Liu YH; Chen HW; Wan YL; Chang HK; Fan KH; Liu HP
    Ann Surg; 2009 Mar; 249(3):392-6. PubMed ID: 19247024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-phosphohistone H3 as an independent prognostic factor in human esophageal squamous cell carcinoma.
    Nakashima S; Shiozaki A; Ichikawa D; Komatsu S; Konishi H; Iitaka D; Kubota T; Fujiwara H; Okamoto K; Kishimoto M; Otsuji E
    Anticancer Res; 2013 Feb; 33(2):461-7. PubMed ID: 23393337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
    Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
    J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma.
    Wang LS; Chow KC; Lien YC; Kuo KT; Li WY
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):419-24. PubMed ID: 15296908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma.
    Gu ZD; Li JY; Li M; Gu J; Shi XT; Ke Y; Chen KN
    Am J Gastroenterol; 2005 Aug; 100(8):1835-43. PubMed ID: 16086722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.